Reolysin reovirus: Phase I

Interim results of a Canadian open-label Phase I dose escalation trial of Reolysin

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE